TY - JOUR
T1 - Outcomes with neuromodulation in obsessive-compulsive disorder
AU - Pallanti, Stefano
AU - Marras, Anna
AU - Grassi, Giacomo
N1 - Publisher Copyright:
© SLACK Incorporated.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Neuromodulation is a new approach for mental disorders resistant to usual treatment that is network pathway-oriented and involves the use of several devices. It represents a promising tool in the quest for “precision medicine” and is aligned with the National Institute of Mental Health’s research domain criteria-based approach for the treatment of brain diseases. In this article, we review currently available data on neuromodulation approaches for obsessive-compulsive disorder (OCD). These approaches are repetitive transcranial magnetic stimulation, deep transcranial magnetic stimulation, and deep brain stimulation (DBS). DBS and, to a lesser degree, transcranial magnetic stimulation, seem to be promising tools for the treatment of resistant and refractory OCD. However, they both remain experimental, and further studies clarifying their long-term outcome and safety are needed. Biomarkers, more precise definitions, and response predictors are also needed and continue to be works-in-progress.
AB - Neuromodulation is a new approach for mental disorders resistant to usual treatment that is network pathway-oriented and involves the use of several devices. It represents a promising tool in the quest for “precision medicine” and is aligned with the National Institute of Mental Health’s research domain criteria-based approach for the treatment of brain diseases. In this article, we review currently available data on neuromodulation approaches for obsessive-compulsive disorder (OCD). These approaches are repetitive transcranial magnetic stimulation, deep transcranial magnetic stimulation, and deep brain stimulation (DBS). DBS and, to a lesser degree, transcranial magnetic stimulation, seem to be promising tools for the treatment of resistant and refractory OCD. However, they both remain experimental, and further studies clarifying their long-term outcome and safety are needed. Biomarkers, more precise definitions, and response predictors are also needed and continue to be works-in-progress.
UR - http://www.scopus.com/inward/record.url?scp=84946831342&partnerID=8YFLogxK
U2 - 10.3928/00485713-20150602-07
DO - 10.3928/00485713-20150602-07
M3 - Article
AN - SCOPUS:84946831342
SN - 0048-5713
VL - 45
SP - 316
EP - 320
JO - Psychiatric Annals
JF - Psychiatric Annals
IS - 6
ER -